UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
FORM 8-K
Current Report
Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934
Date of Report (Date of earliest event reported) September 30, 1997
------------------
Creative Medical Development, Inc.
----------------------------------
(Exact name of registrant as specified in its charter)
Delaware 33-75276 68-0281098
-------- -------- ----------
(State or jurisdiction (Commission (IRS Employer
of incorporation) File Number) Identification No.)
975 SE Sandy Blvd., Portland, Oregon 97214
------------------------------------------
(Address of principal executive offices) (Zip Code)
Registrant's telephone number, including area code (503) 230-8034
--------------
- --------------------------------------------------------------------------------
(Former name or former address, if changed since last report.)
Item 5. Other Events.
The negotiations for an equity investment and the Company's acquisition of
certain assets in exchange for common stock of the Company pursuant to a letter
of intent dated July 30, 1997 terminated approximately October 1, 1997.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
Date: October 30, 1997 Creative Medical Development, Inc.
By: /s/ MICHAEL L. DEBONNY
---------------------------------
Michael L. DeBonny, CEO
